2. Search Result
Search Result
Results for "

PD-183805

" in MedChemExpress (MCE) Product Catalog:
Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-10367
    Canertinib
    5+ Cited Publications

    CI-1033; PD-183805

    		 EGFR Orthopoxvirus Infection Cancer
    Canertinib (CI-1033;PD-183805) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. Canertinib is active against vaccinia virus respiratory infection in mice .
    Canertinib
  • HY-10367A
    Canertinib dihydrochloride
    5+ Cited Publications

    CI-1033 dihydrochloride; PD-183805 dihydrochloride

    		 EGFR Orthopoxvirus Infection Cancer
    Canertinib dihydrochloride (CI-1033 dihydrochloride) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. Canertinib dihydrochloride is active against vaccinia virus respiratory infection in mice .
    Canertinib dihydrochloride
  • HY-10367R
    Canertinib (Standard)

    CI-1033 (Standard); PD-183805 (Standard)

    		 EGFR Orthopoxvirus Infection Cancer
    Canertinib (Standard) is the analytical standard of Canertinib. This product is intended for research and analytical applications. Canertinib (CI-1033;PD-183805) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. Canertinib is active against vaccinia virus respiratory infection in mice[1][2][3][4].
    Canertinib (Standard)
  • HY-10367AR
    Canertinib dihydrochloride (Standard)

    CI-1033 dihydrochloride (Standard); PD-183805 dihydrochloride (Standard)

    		 EGFR Orthopoxvirus Infection Cancer
    Canertinib (dihydrochloride) (Standard) is the analytical standard of Canertinib (dihydrochloride). This product is intended for research and analytical applications. Canertinib dihydrochloride (CI-1033 dihydrochloride) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. Canertinib dihydrochloride is active against vaccinia virus respiratory infection in mice[1][2][3][4].
    Canertinib dihydrochloride (Standard)